Title:
口内乾燥症(xerostomia)の治療のための組成物および方法
Document Type and Number:
Japanese Patent JP7051133
Kind Code:
B2
Abstract:
The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV and formula V and the methods for the treatment of xerostomia may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of oral mucosal inflammatory, dry mouth or oral dry mouth mediated infectious diseases.
Inventors:
Kandura Mahesh
Application Number:
JP2019518221A
Publication Date:
April 11, 2022
Filing Date:
April 19, 2017
Export Citation:
Assignee:
CELLIX BIO PRIVATE LIMITED
International Classes:
C07D405/06; A61K31/385; A61K31/4178; A61P1/02; A61P43/00; C07D339/04
Domestic Patent References:
JP52047911A | ||||
JP62501564A |
Foreign References:
US20090263467 | ||||
US20030185884 | ||||
US20060029665 |
Other References:
IN2004/CH/00354
J. Microencapsulation,2001年,18,173-181
J. Microencapsulation,2001年,18,173-181
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office